NO20003335D0 - FremgangsmÕte for selektiv separering og rensing av eikosapentaen- og dokosaheksaensyrer eller deres estere - Google Patents
FremgangsmÕte for selektiv separering og rensing av eikosapentaen- og dokosaheksaensyrer eller deres estereInfo
- Publication number
- NO20003335D0 NO20003335D0 NO20003335A NO20003335A NO20003335D0 NO 20003335 D0 NO20003335 D0 NO 20003335D0 NO 20003335 A NO20003335 A NO 20003335A NO 20003335 A NO20003335 A NO 20003335A NO 20003335 D0 NO20003335 D0 NO 20003335D0
- Authority
- NO
- Norway
- Prior art keywords
- esters
- eicosapentaene
- purification
- flowing
- diatomaceous earth
- Prior art date
Links
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical class CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 title abstract 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title 1
- 238000000926 separation method Methods 0.000 title 1
- 239000005909 Kieselgur Substances 0.000 abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical class [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 239000004332 silver Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18140799 | 1999-06-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20003335D0 true NO20003335D0 (no) | 2000-06-26 |
NO20003335L NO20003335L (no) | 2000-12-29 |
NO321273B1 NO321273B1 (no) | 2006-04-10 |
Family
ID=16100230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003335A NO321273B1 (no) | 1999-06-28 | 2000-06-26 | Fremgangsmate for selektiv separering og rensing av eikosapentaen- og dokosaheksaensyrer eller deres estere |
Country Status (7)
Country | Link |
---|---|
US (1) | US6313330B1 (no) |
EP (1) | EP1065196B1 (no) |
AT (1) | ATE241584T1 (no) |
CA (1) | CA2311974A1 (no) |
DE (1) | DE60002952T2 (no) |
DK (1) | DK1065196T3 (no) |
NO (1) | NO321273B1 (no) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2251429T3 (pl) | 2003-12-30 | 2017-08-31 | Dsm Ip Assets B.V. | Sposób odpowietrzania |
ES2617577T3 (es) * | 2005-07-08 | 2017-06-19 | Dsm Ip Assets B.V. | Ácidos grasos poliinsaturados para el tratamiento de la demencia y afecciones relacionadas con la pre-demencia |
US20090023808A1 (en) * | 2007-06-29 | 2009-01-22 | Martek Biosciences Corporation | Production and Purification of Esters of Polyunsaturated Fatty Acids |
ES2862336T3 (es) | 2008-09-02 | 2021-10-07 | Amarin Pharmaceuticals Ie Ltd | Composición farmacéutica que comprende ácido eicosapentaenoico y ácido nicotínico y métodos de uso de la misma |
JP5503856B2 (ja) | 2008-09-10 | 2014-05-28 | キユーピー株式会社 | 高度不飽和脂肪酸誘導体の取得方法 |
JP5872453B2 (ja) | 2009-04-17 | 2016-03-01 | ナタク ファルマ エセ.エレ. | フィタン酸含量が低く、ω−3脂肪酸に富む組成物 |
WO2010127099A2 (en) | 2009-04-29 | 2010-11-04 | Amarin Corporation Plc | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
NZ595852A (en) | 2009-04-29 | 2014-07-25 | Amarin Pharmaceuticals Ie Ltd | Stable pharmaceutical composition comprising ethyl eicosapentaenoate |
SMT202100223T1 (it) | 2009-06-15 | 2021-05-07 | Amarin Pharmaceuticals Ie Ltd | Composizioni e metodi per abbassare i trigliceridi senza aumentare i livelli di ldl-c in un soggetto in terapia concomitante con statine |
RU2012116079A (ru) | 2009-09-23 | 2013-10-27 | АМАРИН КОРПОРЕЙШН ПиЭлСи | Фармацевтическая композиция, включающая омега-3 жирную кислоту и гидроксипроизводное статина и способы ее применения |
KR101761959B1 (ko) | 2009-12-30 | 2017-07-26 | 바스프 파마 (칼라니쉬) 리미티드 | 다중 불포화 지방산을 정제하기 위한 시뮬레이션된 이동상 크로마토그래피 분리 방법 |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
EP2646013A4 (en) | 2010-11-29 | 2014-03-26 | Amarin Pharma Inc | COMPOSITION WITH LOW IMPACT EFFECT AND METHOD FOR THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES IN A PATIENT WITH FISH ALLERGY / SENSITIVITY |
GB201111594D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New improved process |
GB201111595D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Improved process |
GB201111589D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New modified process |
GB201111601D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New process |
GB201111591D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Further new process |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
US20130131170A1 (en) | 2011-11-07 | 2013-05-23 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
US9827219B2 (en) | 2012-01-06 | 2017-11-28 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject |
NZ703267A (en) | 2012-06-29 | 2017-01-27 | Amarin Pharmaceuticals Ie Ltd | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy |
US20150265566A1 (en) | 2012-11-06 | 2015-09-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9814733B2 (en) | 2012-12-31 | 2017-11-14 | A,arin Pharmaceuticals Ireland Limited | Compositions comprising EPA and obeticholic acid and methods of use thereof |
GB201300354D0 (en) | 2013-01-09 | 2013-02-20 | Basf Pharma Callanish Ltd | Multi-step separation process |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
US9428711B2 (en) | 2013-05-07 | 2016-08-30 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
US8802880B1 (en) | 2013-05-07 | 2014-08-12 | Group Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
CN103962091B (zh) * | 2013-11-28 | 2017-01-25 | 大连工业大学 | 一种银离子改性氨基硅胶分离epa和dha的方法 |
EP2883860B1 (fr) | 2013-12-11 | 2016-08-24 | Novasep Process | Procédé chromatographique de production d'acides gras polyinsaturés |
US10975031B2 (en) | 2014-01-07 | 2021-04-13 | Novasep Process | Method for purifying aromatic amino acids |
US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
US10172818B2 (en) | 2014-06-16 | 2019-01-08 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
WO2018213663A1 (en) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
PL4056176T3 (pl) | 2018-09-24 | 2024-08-26 | Amarin Pharmaceuticals Ireland Limited | Sposoby zmniejszania ryzyka zdarzeń krążeniowo-naczyniowych u osobnika |
US11767491B2 (en) | 2019-03-26 | 2023-09-26 | Nisshin Pharma Inc. | Eicosapentaenoic acid alkyl ester-containing composition and method for producing same |
CN109912403A (zh) * | 2019-04-18 | 2019-06-21 | 南京市第一医院 | 一种Omega-3制备大电导钙激活钾通道开放剂的方法 |
KR20240012390A (ko) | 2021-04-21 | 2024-01-29 | 애머린 파마슈티칼스 아일랜드 리미티드 | 심부전의 위험을 감소시키는 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0347509A1 (en) * | 1988-06-21 | 1989-12-27 | Century Laboratories Inc. | A process of extraction and purification of polyunsaturated fatty acids from natural sources |
JPH028298A (ja) * | 1988-06-17 | 1990-01-11 | Agency Of Ind Science & Technol | イカ内臓からドコサヘキサエン酸及びエイコサペンタエン酸を選択的に分離精製する方法 |
JPH07242895A (ja) * | 1993-03-16 | 1995-09-19 | Ikeda Shiyotsuken Kk | 高純度エイコサペンタエン酸又はその低級アルコールエステルの分離精製法 |
JPH09151390A (ja) * | 1995-11-30 | 1997-06-10 | Bizen Kasei Kk | 高度不飽和脂肪酸及びその誘導体の精製方法 |
JPH10310551A (ja) * | 1997-05-12 | 1998-11-24 | Nippon Wax Polymer Kaihatsu Kenkyusho:Kk | エイコサペンタエン酸又はそのエステルの精製方法 |
-
2000
- 2000-06-19 CA CA002311974A patent/CA2311974A1/en not_active Abandoned
- 2000-06-21 AT AT00113020T patent/ATE241584T1/de not_active IP Right Cessation
- 2000-06-21 DK DK00113020T patent/DK1065196T3/da active
- 2000-06-21 DE DE60002952T patent/DE60002952T2/de not_active Expired - Fee Related
- 2000-06-21 EP EP00113020A patent/EP1065196B1/en not_active Expired - Lifetime
- 2000-06-26 NO NO20003335A patent/NO321273B1/no unknown
- 2000-06-28 US US09/604,766 patent/US6313330B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2311974A1 (en) | 2000-12-28 |
DE60002952T2 (de) | 2004-03-11 |
ATE241584T1 (de) | 2003-06-15 |
US6313330B1 (en) | 2001-11-06 |
NO321273B1 (no) | 2006-04-10 |
DE60002952D1 (de) | 2003-07-03 |
EP1065196A1 (en) | 2001-01-03 |
NO20003335L (no) | 2000-12-29 |
EP1065196B1 (en) | 2003-05-28 |
DK1065196T3 (da) | 2003-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003335L (no) | Fremgangsmåte for selektiv separering og rensing av eikosapentaen- og dokosaheksaensyrer eller deres estere | |
JP5951764B2 (ja) | 魚油から高純度のepaを生成するためのsmb方法 | |
ES2459951T3 (es) | Proceso de separación cromatográfico de lecho móvil simulado para la purificación de ácidos grasos poliinsaturados | |
JP5990580B2 (ja) | 新規なsmb方法 | |
JP5946833B2 (ja) | ω3脂肪酸を濃縮する方法 | |
IS5133A (is) | Hreinsun á fjölómettuðum fitusýruglýseríðum | |
ATE406345T1 (de) | Reinigung von aminosäuren durch chromatographische simulierte wanderbetttrennung | |
ATE200293T1 (de) | Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen | |
ES2097047T3 (es) | Procedimientos para el fraccionamiento cromatografico de acidos grasos y sus derivados. | |
JP2014518312A (ja) | Smb方法 | |
BR112014000147B1 (pt) | processo de separação cromatográfica, produto de pufa | |
CN101830956A (zh) | 猪胆膏或下脚料中鹅去氧胆酸的分离纯化制备方法 | |
BR9808785A (pt) | Processos para produzir ésteres de citrato | |
ATE8785T1 (de) | Kohlstoff-koffein-trennung. | |
ES2905647T3 (es) | Proceso para la producción de ácido graso altamente insaturado de una pureza alta con un rendimiento alto | |
JPH08218091A (ja) | 高純度の高度不飽和脂肪酸およびその誘導体の製造方法 | |
JP2017504683A (ja) | クロマトグラフィ法による脂肪酸の精製 | |
IT1277685B1 (it) | Procedimento per la riduzione di acqua e di impurezze polari in acidi immido-alcanpercarbossilici | |
JP6464144B2 (ja) | ステアリドン酸の精製方法 | |
RU2698720C1 (ru) | Способ получения докозагексаеновой кислоты | |
ES8704186A1 (es) | Procedimiento para aislar y purificar x-interferones plasmidogenos. | |
JPS56115736A (en) | Separation and purification of eicosapentaenoic acid and docosahexaenoic acid | |
DE50010982D1 (de) | Verfahren zur herstellung von spezifikationsgerechtem phthalsäureanhydrid | |
NO891069D0 (no) | Fremgangsmaate for rensing av uren alfa-l-aspartyl-l-fenylalaninmethylester (alfa-apm). | |
FR2646669B1 (fr) | Procede de separation enantiomeriquement selective des esters des acides halogeno-2 propioniques |